Could A Nasal Vaccine Finally Get Rid Of The Black Death?

December 02, 1998

NOSE drops can protect mice from bubonic plague, the disease that wiped out a third of Europe's population in the 14th century. If this new vaccine also works in human trials, it may allay fears of a worldwide pandemic started by antibiotic-resistant plague bacteria.

Round the world, one to two thousand cases of the plague are reported each year. Bubonic plague is caused by the bacterium Yersinia pestis, which is spread by fleas that live on rodents. But the bacteria can also spread directly into the lungs through infected droplets coughed out by sick people. This pneumonic plague spreads faster and is more deadly than the bubonic form, and was the main cause of the Black Death.

Antibiotics can save someone with pneumonic plague if they get treatment within 18 hours of infection. But last year, researchers found plague bacteria in Madagascar carrying five different antibiotic resistance genes. This raised the spectre of a pneumonic plague pandemic. The disease could also become a weapon in the hands of bioterrorists.

Many researchers pin their hopes on an effective vaccine. The only vaccine now licensed for plague, which consists of killed bacteria, protects just half its recipients. Clinical trials of a vaccine that may be more effective will start next year. "But that vaccine must be injected, which presents logistical problems if you have to give it quickly to 100 000 soldiers or civilians," says Rick Titball of Britain's Defence Evaluation Research Agency in Porton Down, Wiltshire. Ideally, he adds, the vaccine should be in a form that can target tissue lining the gut or respiratory system.

That is what Oya Alpar and her colleagues at the University of Birmingham have come up with. They took a protein from the surface of Y. pestis and combined it with another that is secreted by the bacterium. They encapsulated the proteins in polylactic acid polymers to stop them being broken down by enzymes in the body before reaching their target.

The researchers say mice whose noses and throats were treated with the vaccine were fully protected from inhaled Y. pestis (Vaccine, vol 16, p 2000). Tests showed that the capsules released the proteins for several weeks, and the mice produced two types of antibodies: one secreted by the tissue lining the gut and respiratory system, and another which circulates in the blood.

Alpar says a nasal spray based on this vaccine could be a viable means of protecting people from pneumonic plague, and she is planning clinical trials. "We think this is a promising approach for a whole range of diseases," she adds. "We are looking at similar vaccines for tetanus and diphtheria."
Please mention New Scientist as the source of this article - Thank you.

UK CONTACT - Claire Bowles, New Scientist Press Office, London:
Tel: 44-171-331-2751 or email
US CONTACT - Barbara Thurlow, New Scientist Washington office:
Tel: 202-452-1178 or email

New Scientist

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to